The AGA Journals Blog highlights the latest discoveries in gastroenterology and hepatology research.

learning from experience

Day: September 3, 2013

A New Drug for Diabetes and Fatty Liver Disease?

Obeticholic acid (OCA)—an agonist of the farnesoid X receptor (FXR)— increases insulin sensitivity and reduces markers of liver inflammation and fibrosis in patients with type

Related Posts Plugin for WordPress, Blogger...
Read More

About The Author

Dr. Kristine Novak

Dr. Kristine Novak

Dr. Kristine Novak is a science writer and editor based in San Francisco. She has extensive experience covering gastroenterology, hepatology, immunology, oncology, clinical, and biotechnology research discoveries.

Top Viewed

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn

Subscribe

We never use your email for anything other than The AGA Journals Blog.